Bumetanide Tablet
Product Images NDC 72888-021

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 72888-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bumetanide Tablets USP 0.5 mg)

This text is information about a medication containing Bumetanide USP 0.5 mg per tablet. It mentions the usual dosage and storage instructions. It also provides details about packaging, distribution, and manufacturing of the tablets. To learn more, you can refer to the package insert available at advagenpharm.com.*

FDA Label Image

Principal Display Panel (Bumetanide Tablets USP 1 mg)

This is not readable.*

FDA Label Image

Principal Display Panel (Bumetanide Tablets USP 2 mg)

This is a description of a medication containing 2 mg of Bumetanide. The tablets are distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. The usual dosage information can be found in the prescribing information, and the tablets should be stored at 20°C to 25°C (68°F to 77°F). The text also mentions that excursions from 15°C to 30°C (59°F-86'F) are permitted. The drugs should be kept out of reach of children. The package insert is available at the website mentioned in the text.*

FDA Label Image

Chemical Structural Formula (Bumetanide Tablets Usp Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.